EU regulator backs use of Wegovy for obesity-related heart disease

The European Medicines Agency has backed the use of Novo Nordisk’s vaccine, the popular drug Wegovy, to help relieve heart failure in people with obesity, the Danish drugmaker announced.

Compartir esta publicacion:

ENTRADAS POPULARES
SÍGANOS
Danos like en facebook
Síganos en Twitter
Suscríbase a nuestro canal
Tik Tok
TRANSMISIÓN EN VIVO